📑 Extensive Product Profile: Understanding Caprelieva 500mg Tablet

Caprelieva 500mg Tablet contains Vandetanib, an advanced oral multi-kinase inhibitor (tyrosine kinase inhibitor). Developed and manufactured to the highest global pharmaceutical protocols, it serves as a frontline targeted anti-neoplastic intervention utilized by oncologists worldwide to manage rare, aggressive, and mutation-driven endocrine malignancies.

1. Clinical Indications & Usage

Caprelieva 500mg is an oral targeted therapy globally indicated for:

• Medullary Thyroid Cancer (MTC): Indicated for the treatment of symptomatic, aggressive, unresectable locally advanced or metastatic medullary thyroid cancer in adult patients.

• Clinical Determination Framework: Because of treatment-related risks, selective clinical judgment must be applied to determine therapy initiation for patients with slowly progressive disease.

2. Mechanism of Action: How Caprelieva Works

Caprelieva blocks several key signaling pathways that cancer cells depend on to grow and spread:

• Tyrosine Kinase Cascade Inhibition: Vandetanib selectively blocks the intracellular tyrosine kinase activity of the EGFR (Epidermal Growth Factor Receptor) and VEGFR (Vascular Endothelial Growth Factor Receptor) families, specifically targeting VEGFR-2, which controls tumor blood supply.

• RET Oncogene Targeting: It directly inhibits the RET (Rearranged during Transfection) receptor tyrosine kinase. Mutations in the RET oncogene are the primary genetic driver behind inherited and sporadic medullary thyroid carcinomas.

• Anti-Angiogenesis & Apoptosis: By blocking these pathways simultaneously, Caprelieva cuts off the tumor's ability to develop new blood vessels (angiogenesis), starves the growth signals of the tumor cells, and pushes them toward programmed cell death (apoptosis).

3. Administration and Dosing Guide

• Administration Route: Caprelieva 500mg is an oral tablet formulation. It must be swallowed whole with water and should never be crushed, chewed, split, or dissolved due to the risk of chemical exposure.

• Food Interactions: Tablets can be taken consistently either with or without food.

• Standard Schedule: The typical recommended adult starting dosage is 300 mg per day (administered via lower strength tablets) or titrated up to 500 mg per day as a single oral dose based on precise patient tolerance, clinical progression, and specific institutional protocols managed by the supervising oncologist.

• Missed Dose: If a dose is missed by more than 12 hours, the patient should skip it and resume with the next scheduled daily dose.]

⚠️ Safety, Side Effects, and Monitoring

Caprelieva 500mg is a highly potent multi-kinase inhibitor requiring intensive clinical oversight:

• QT Prolongation and Torsades de Pointes: Caprelieva can severely prolong the QT interval, which can lead to life-threatening heart arrhythmias. Baseline and periodic ECGs and electrolyte monitoring (potassium, calcium, magnesium) are mandatory.

• Severe Dermatological Toxicity: Can cause severe skin reactions including Stevens-Johnson syndrome or toxic epidermal necrolysis. Photosensitivity is common; skin protection from UV light is required.

• Interstitial Lung Disease (ILD): Rare but serious instances of non-infectious respiratory inflammation can occur. Patients presenting with sudden dyspnea, cough, or fever must be evaluated immediately.

• Common Side Effects: Diarrhea, rash, acne, nausea, high blood pressure (hypertension), headache, fatigue, loss of appetite, and abdominal pain.

📦 Storage and Handling Specifications

• Storage Framework: Store Caprelieva 500mg tablets consistently below 30°C (86°F) in a dry, dark climate-controlled warehouse framework.

• Environmental Safeguards: Keep tablets sealed tightly inside their original manufacturer packaging. Protect the blister strips/bottles from high humidity, excess ambient moisture, and direct UV light exposure. Keep strictly out of reach of children and domestic animals.

📄 Regulatory and Compliance Documentation

PRIMECARE IMPEX simplifies international border clearance and institutional sourcing workflows by providing a comprehensive, audit-ready document pack with every consignment:

• Authentic Certificate of Analysis (COA) 

• Verified Batch Origin Ledger and commercial export documentation.

• GMP compliant manufacturing sourcing credentials.

💡 Why Choose PRIMECARE IMPEX?

Sourcing through PRIMECARE IMPEX ensures professional-grade, secured supply-chain setups for global hospital networks and commercial distribution channels:

• Traceability

• Regulatory Support

• Secure Bulk Supply

📞 Contact PRIMECARE IMPEX — Pharmaceutical Exporter from India

[GROUP OF PRIME CARE IMPEX PVT. LTD.]

Your Trusted Pharmaceutical Exporter, Bulk Supplier, and Global Distributor from India.

• 🌐 Corporate Website: www.medicineexporterfromindia.com

• 📧 Commercial Email: exports@ernestpharmaceuticals.com

• 📦 Business Type: Exporter | Bulk Supplier | Distributor

• 📲 Direct WhatsApp Line: +91 9673008130

• 🔗 Instant Chat Access: https://wa.me/919673008130